Vol 9, Supplement 1 (February 28, 2020): Translational Lung Cancer Research (Mesothelioma: What We know and What We Do Not Know in 2020)

Editorial

This special volume of mesothelioma is dedicated to my friend Adi Gazdar

Michele Carbone

PDF Pages: S1-S2 Full Text (1304) Open Access

Review Article

Application of immunohistochemistry in diagnosis and management of malignant mesothelioma

David B. Chapel, Jefree J. Schulte, Aliya N. Husain, Thomas Krausz

PDF Pages: S3-S27 Full Text (13701) Open Access

Epidemiology of mesothelioma in the 21^st century in Europe and the United States, 40 years after restricted/banned asbestos use

Naomi Alpert, Maaike van Gerwen, Emanuela Taioli

PDF Pages: S28-S38 Full Text (6789) Open Access

How asbestos and other fibers cause mesothelioma

Giovanni Gaudino, Jiaming Xue, Haining Yang

PDF Pages: S39-S46 Full Text (6846) Open Access

SV40 and human mesothelioma

Michele Carbone, Adi Gazdar, Janet S. Butel

PDF Pages: S47-S59 Full Text (12639) Open Access

BAP1: role in carcinogenesis and clinical implications

Daniel A. Kobrinski, Haining Yang, Muaiad Kittaneh

PDF Pages: S60-S66 Full Text (4742) Open Access

Mesothelioma developing in carriers of inherited genetic mutations

Yoshie Yoshikawa, Mitsuru Emi, Takashi Nakano, Giovanni Gaudino

PDF Pages: S67-S76 Full Text (3756) Open Access

Chemotherapy options versus “novel” therapies: how should we treat patients with malignant pleural mesothelioma

Maria J. Disselhorst, Paul Baas

PDF Pages: S77-S85 Full Text (1906) Open Access

Surgery for pleural mesothelioma, when it is indicated and why: arguments against surgery for malignant pleural mesothelioma

Gavitt A. Woodard, David M. Jablons

PDF Pages: S86-S91 Full Text (4156) Open Access

Chromosomal rearrangements and their neoantigenic potential in mesothelioma

Aaron Scott Mansfield, Tobias Peikert, George Vasmatzis

PDF Pages: S92-S99 Full Text (2066) Open Access

Immunotherapy for mesothelioma: a critical review of current clinical trials and future perspectives

Steven G. Gray, Luciano Mutti

PDF Pages: S100-S119 Full Text (10614) Open Access

Peritoneal mesothelioma

Alissa Greenbaum, H. Richard Alexander

PDF Pages: S120-S132 Full Text (4883) Open Access

Obituary

Adi Gazdar, MD: one of the founders of the molecular pathology of cancer, a great scientist and a great man

John D. Minna

PDF Pages: S133-S136 Full Text (1618) Open Access

Disclosure:

The supplement “Mesothelioma: What We know and What We Do Not Know in 2020” was commissioned by the editorial office, Translational Lung Cancer Research without any sponsorship or funding. Michele Carbone served as the unpaid Guest Editor for the supplement.